Literature DB >> 7017079

Immunological aspects of intrinsic glial tumors.

M L Apuzzo, M S Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7017079     DOI： 10.3171/jns.1981.55.1.0001

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  19 in total

1.  Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors.

Authors:  S K Sankhla; J S Nadkarni; S N Bhagwati
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

2.  Immunobiology of brain tumors.

Authors:  E Frank; N de Tribolet
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

3.  A pilot study of recombinant interferon beta (IFN-beta ser) in patients with recurrent glioma.

Authors:  W K Yung; A M Castellanos; P Van Tassel; R P Moser; S G Marcus
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

Review 4.  Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations.

Authors:  R E Merchant; M D Ellison; H F Young
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

5.  Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.

Authors:  K B Quattrocchi; C H Miller; S Cush; S A Bernard; S T Dull; M Smith; S Gudeman; M A Varia
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

6.  The mononuclear cell infiltrate compared with survival in high-grade astrocytomas.

Authors:  M L Rossi; N R Jones; E Candy; J A Nicoll; J S Compton; J T Hughes; M M Esiri; T H Moss; F F Cruz-Sanchez; H B Coakham
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 7.  Immunology of gliomas.

Authors:  N de Tribolet
Journal:  Childs Nerv Syst       Date:  1989-04       Impact factor: 1.475

8.  Organization of F-actin filaments in human glioma cell lines cultured on extracellular matrix proteins.

Authors:  N Nagano; M Aoyagi; K Hirakawa; M Yamamoto; K Yamamoto
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

9.  Particular features of cell-mediated immunity in patients with anaplastic gliomas. A comparison with kidney and bladder cancer patients.

Authors:  F Servadei; R Parente; M Bucci; E Beltrandi; F Tognetti; G Gaist
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

10.  Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.